Comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 vs 3q26 Microduplication Syndrome C4755319
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Androgens Excess and 3q26 Microduplication Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
A condition where an XX individual has excess male hormones causing atypical genital development. It affects both newborns and older individuals. Treatment may involve hormone management and surgical options.
3q26 Microduplication Syndrome C4755319
A genetic condition involving extra genetic material at chromosome 3q26, which can cause developmental delays and other features depending on specific genes involved.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
0-null
3q26 Microduplication Syndrome C4755319
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
severe
3q26 Microduplication Syndrome C4755319
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
Chronic
3q26 Microduplication Syndrome C4755319
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
No
3q26 Microduplication Syndrome C4755319
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
reproductive
3q26 Microduplication Syndrome C4755319
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
endocrine
3q26 Microduplication Syndrome C4755319
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-androgens-excess-C5680227 and 3q26-microduplication-syndrome-C4755319 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 3q26 Microduplication Syndrome C4755319 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may occur in an XX individual with androgen excess. | Genital findings are not established; features depend on involved genes. | High |
| Development | Developmental delay is not established as a core feature. | Developmental delay may occur, with variable additional features. | Moderate |
| Cause category | Endocrine androgen excess in a 46,XX context. | Extra genetic material at chromosome 3q26. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 when
Atypical genitalia with confirmed or suspected 46,XX karyotype
The supplied concept centers on androgen-related sex development.
High
Endocrine evaluation suggests androgen excess
Hormone findings fit the endocrine category better than a copy-number diagnosis.
Moderate
Primary concern is reproductive or genital development
The source assigns the reproductive system and endocrine category.
Moderate
Choose 3q26 Microduplication Syndrome C4755319 when
Developmental delay with congenital features
This pattern aligns with the described genetic syndrome.
Moderate
Microarray shows extra material at 3q26
A detected duplication directly supports this concept.
High
No evidence of isolated androgen-related 46,XX DSD
A broader congenital genetic explanation may be more appropriate.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 3q26 Microduplication Syndrome C4755319 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is part of the concept. | No specific karyotype is established by the source. | Karyotype alone does not prove either cause. |
| Chromosomal microarray | Not expected to define androgen excess. | May show gain at 3q26. | A positive result supports the genetic concept; absence needs clinical review. |
| Androgen-related endocrine testing | May support excess androgens; no cutoff is supplied. | No characteristic endocrine result is established. | Abnormal hormones are findings, not a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
- Outcome
- Described as severe and chronic, but individual outcome is not established.
- Factors
- Hormone cause, anatomy, and response to clinician-directed care may matter.
3q26 Microduplication Syndrome C4755319
- Outcome
- Described as moderate and chronic, with variable effects.
- Factors
- Duplication size and involved genes may influence features.
Time frame: Onset and long-term course are not established in the source.
Prognosis cannot be generalized from these sparse descriptions.
Complications comparison
| Complication | Presentation |
|---|---|
| Anatomic or congenital effects | Atypical genital development may need specialist assessment. Congenital or developmental features vary by genes involved. Exact complications and frequency are not established. |
| Endocrine effects | Ongoing hormone imbalance may require management. Endocrine complications are not established. Do not infer doses, thresholds, or treatment response. |
| Support needs | Psychosocial and reproductive counseling may be relevant. Developmental and educational support may be relevant. Needs should be individualized by clinicians. |
Patient education highlights
- HighDifferent conditions
These labels describe different mechanisms and should not be used interchangeably.
- HighTesting limits
A test abnormality is not automatically a diagnosis; results need specialist interpretation.
- MediumCare planning
Ask about genetics, endocrinology, and developmental follow-up appropriate to the confirmed finding.